AVROBIO
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AVROBIO and buy or sell other stocks, ETFs, and their options commission-free!About AVRO
Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of therapeutic proteins and antibodies that modulate the activity of G protein-coupled receptors (GPCR). It develops a proprietary technology platform called GEODe to enable the discovery and development of GPCR-targeted biologic medicines.
CEOAlise S. Reicin, MD
CEOAlise S. Reicin, MD
Employees51
Employees51
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
Founded
Employees51
Employees51
AVRO Key Statistics
Market cap390.71M
Market cap390.71M
Price-Earnings ratio-5.42
Price-Earnings ratio-5.42
Dividend yield—
Dividend yield—
Average volume435.04K
Average volume435.04K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$61.07
52 Week high$61.07
52 Week low$13.70
52 Week low$13.70
Stock Snapshot
The current AVROBIO(AVRO) stock price is $20.88, with a market capitalization of 390.71M. The stock trades at a price-to-earnings (P/E) ratio of -5.42.
During the trading day, AVROBIO(AVRO) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for AVROBIO(AVRO) stock has reached 0, versus its average volume of 435.04K.
Over the past 52 weeks, AVROBIO(AVRO) stock has traded between a high of $61.07 and a low of $13.70.
Over the past 52 weeks, AVROBIO(AVRO) stock has traded between a high of $61.07 and a low of $13.70.
People also own
Based on the portfolios of people who own AVRO. This list is generated using Robinhood data, and it’s not a recommendation.